VBI Vaccines announced progress of Coronavirus vaccine program
On Jan. 21, 2021, VBI Vaccines announced that it expected to initiate the first Phase 1/2 clinical study…
-
-
Cepheid received Health Canada license for SARS-CoV-2, Flu A, Flu B and RSV combination test
On Jan. 14, 2021, Cepheid that Health Canada announced that it had issued Cepheid a medical device license…
-
SIGA announced Public Health Agency of Canada contract to purchase $33 million of Oral TPOXX
On Jan. 13, 2021, SIGA Technologies announced that the Public Health Agency of Canada had awarded a contract…
-
Health Canada authorized Moderna COVID-19 vaccine in Canada
On Dec. 23, 2020, Moderna announced that Health Canada had authorized its vaccine against COVID-19 for the immunization…
-
Canada exercised increased option for total of 40 million doses of mRNA vaccine candidate against COVID-19
On Dec. 7, 2020, Moderna announced that the Canadian Government had increased its confirmed order commitment by 20…
-
VBI Vaccines partnered with Syneos Health for commercialization of prophylactic 3-antigen hepatitis B vaccine
On Dec. 4, 2020, VBI Vaccines and Syneos Health announced a partnership for the commercialization of VBIﾒs 3-antigen…
-
Merck submited applications for licensure of V114, 15-valent pneumococcal conjugate vaccine, for use in adults
On Nov. 23, 2020, Merck, known as MSD outside the U.S. and Canada, announced the company had submitted…
-
Lilly’s neutralizing antibody bamlanivimab received interim authorization from Health Canada as treatment for COVID-19
On Nov. 20, 2020, Eli Lilly announced that Health Canada had granted authorization under the Interim Order Respecting…
-
BD announced Canadian Government order of 76 million portable, rapid point-of-care antigen tests to detect SARS-CoV-2
On Nov. 10, 2020, BD (Becton, Dickinson) announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the…
-
Abbottr received Health Canada Authorization under Interim Order to use FreeStyleﾮ Libre System for hospitalized patients during COVID-19 pandemic
On Apr. 27, 2020, Abbott announced that Health Canada authorized use of FreeStyle Libre system, a sensor-based glucose…
-
Bausch Health initiated VIRAZOLEﾮ (Ribavirin for inhalation solution, USP) clinical study in patients with COVID-19
On Apr. 13, 2020, Bausch Health announced it has initiated a clinical trial program in Canada evaluating an…
-
Stanford-led team developed privacy-focused coronavirus alert app
On Apr. 9, 2020, James Petrie, a graduate student in applied mathematics at the University of Waterloo in…
-
Government of Canada invested $27 million in Coronavirus research
On Mar. 6, 2020, to further contribute to global efforts to address the COVID-19 outbreak, Canada’s Minister of…
-
Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
-
Government of Canada and partners invested $18 million in crucial microbiome research
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
-
Ontario Institute for Cancer Research leukemia therapy discovery received approximately $1 billion in funding from Celgene
On Jan. 29, 2019, Ontario Institute for Cancer Research’s (OICR) Drug Discovery Program’s first-of-its-kind leukemia therapy discovery received…
-
Canadian researchers reconstituted an extinct poxvirus using mail-order DNA
On Jul 6, 2017, a group led by virologist David Evans of the University of Alberta in Edmonton,…
-
Canada Foundation awarded $6 million for Innovation Metabolomics Innovation Centre at the University of Alberta
On Jan. 9, 2017, the Canada Foundation for Innovation (CFI) awarded $6 million for Canada’s national metabolomics laboratory,…
-
The Danforth Foundation’s made final gift of $70 million to the Donald Danforth Plant Science Center
On Jan. 12, 2011, The Danforth Foundation’s made a final gift of $70 million to the Donald Danforth…
-
The first preventative vaccine for HIV was developed at University of Western Ontario
On Dec. 20, 2011, the U.S. Food and Drug Administration (FDA) announced approval of the first and only…
-
Andras Nagy reported the discovery of a new non-viral method of creating stem cells from other cells of the body
In 2009, Dr. Andras Nagy reported the discovery of a new non-viral method of creating stem cells from…
-
Andras Nagy announced Canada’s first human embryonic stem cell lines
On Jun 8, 2005, Dr. Andras Nagy at Mount Sinai Hospital announced Canada’s first human embryonic stem cell…
-
The National Institute for Nanotechnology was founded
In 2005, the National Institute for Nanotechnology (NINT) was founded as a joint initiative between the Government of…
-
Genome Alberta was established
In 2005, Genome Alberta, was established in partnership with Genome Canada Industry Canada and the Province of Alberta,…
-
Biotechnology | HIV | Therapeutics | Vaccine
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On February 24 2003, VaxGen announced that AIDSVAX B/B did not prove effective in the trials conducted in…
-
National Cancer Institute and ACRIN launched first multicenter study to compare digital mammography
On Sept. 4. 2001, the National Cancer Institute (NCI) and the American College of Radiology Imaging Network launched…
-
SynCardia Systems was founded
In 2001, SynCardia Systems, a private company formed to commercialize the Jarvik 7 artificial heart, was founded by…
-
Eli Lilly and Takeda Chemical Industries launched Actos, an oral antidiabetes agent
In 2000, Eli Lilly and Takeda Chemical launched Actos, an oral anti diabetes agent. In 2005, a PROactive…
-
The Prostate Centre at VGH received $20 million donation by Vancouver businessman Jim Pattison
In 1999, the Vancouver Prostate Centre received a $20 million donation by Vancouver businessman Jim Pattison, the largest…
-
Michael Smith Genome Science Centre was founded
In 1999, Michael Smith, recipient of the 1993 Nobel Prize in Chemistry, founded Canada’s Michael Smith Genome Science…
